Prospective Study of Gefitinib in Epidermal Growth Factor Receptor Fluorescence In Situ Hybridization–Positive/Phospho-Akt–Positive or Never Smoker Patients With Advanced Non–Small-Cell Lung Cancer: The ONCOBELL Trial (Q62992066)
Jump to navigation
Jump to search
scientific article published on 01 June 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prospective Study of Gefitinib in Epidermal Growth Factor Receptor Fluorescence In Situ Hybridization–Positive/Phospho-Akt–Positive or Never Smoker Patients With Advanced Non–Small-Cell Lung Cancer: The ONCOBELL Trial |
scientific article published on 01 June 2007 |
Statements
Prospective study of gefitinib in epidermal growth factor receptor fluorescence in situ hybridization-positive/phospho-Akt-positive or never smoker patients with advanced non-small-cell lung cancer: the ONCOBELL trial (English)
Marileila Varella-Garcia
Claudia Ligorio
Luca Toschi
Elisa Rossi
Daniela Paioli
Elisabetta Magrini
Giovanna Finocchiaro
Stefania Bartolini
Alessandra Cancellieri
Marco Patelli
Lucio Crino
Pasi A Jänne
Alison J Holmes